»ó´Ü¿©¹é
±â»ç (Àüü 918°Ç)
[Sub Story] SGLT-2 ¾ïÁ¦Á¦ ´ÙÆı۸®Ç÷ÎÁø º¸Çè±Þ¿© È®´ë ÀÓ¼¼Çü ±âÀÚ 2016-02-21 22:21
[Sub Story] DPP-4 ¾ïÁ¦Á¦ ¾Ë·Î±Û¸³Æ¾ Á×»ó°æÈ­Áõ ¾ïÁ¦È¿°ú È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2016-02-21 17:30
[Drug Review] Çѱ¹ÀÎ Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ Å׳׸®±Û¸³Æ¾ È¿°ú ¹× ¾ÈÀü¼º ÀÓ¼¼Çü ±âÀÚ 2016-02-21 15:49
[Interview] ¡°´ç´¢º´ ȯÀÚÀÇ ½ÉÇ÷°üÁúȯ ¿¹¹æÀü·«, ÁöÁú¡¤Ç÷¾Ð ÇÔ²² °ü¸®Çؾߡ± ÀÓ¼¼Çü ±âÀÚ 2016-02-21 14:57
[¹ÌºÐ·ù] [¼ÒÈ­±â]HCV 3Çü ABT-530 Æ÷ÇÔ 3Á¦¿ä¹ý ÀÓ¼¼Çü ±âÀÚ 2016-02-17 09:07
¶óÀÎ
[Sub Story] »õ·Î¿î ±×¸² ±×·ÁÁø Àν¶¸° Ä¡·áÀü·« ÀÓ¼¼Çü ±âÀÚ 2016-02-01 19:27
[Cover Story] ¼ÒÈ­±âÁúȯ °ü¸®, ÃֽűٰŷΠ¹«Àå ¹Ì·¡¸¦ ´ëºñÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2016-01-29 18:00
[Conference Report] 2015³â ¹Ì±¹°£ÇÐȸ ¿¬·ÊÇмú´ëȸ ÀÓ¼¼Çü ±âÀÚ 2016-01-29 17:55
[Sub Story] DAA Àü·«½Ã´ë °øÇ¥¡¦Àû±ØÀû ¼±º°°Ë»ç °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2016-01-29 17:12
[Interview] ¡°±¹³» DAA ½Ã´ë ¿©´Â ±Ù°Å Á᫐ °¡À̵å¶óÀΡ± ÀÓ¼¼Çü ±âÀÚ 2016-01-29 17:09
¶óÀÎ
[Drug Review] ¼Ò¹ßµð, CÇü°£¿° Ä¡·á Æз¯´ÙÀÓ ÀüȯÀÇ ½ÃÀÛ ÀÓ¼¼Çü ±âÀÚ 2016-01-29 17:05
[Drug Review] ÇϺ¸´Ï, CÇü°£¿° À¯ÀüÀÚÇü 1ÇüÀÇ ¿ì¼± Ä¡·áÀü·« ÀÓ¼¼Çü ±âÀÚ 2016-01-29 17:03
[Sub Story] ±¹³» BÇü°£¿° °¨¼Ò¼¼, ȯÀÚ°ü¸® ¿ªÁ¡ µÖ¾ß ÀÓ¼¼Çü ±âÀÚ 2016-01-29 17:00
[Sub Story] BÇü°£¿° ³»¼º¿¡ Å׳ëÆ÷ºñ¸£ ´Üµ¶¿ä¹ý ÀÓ¼¼Çü ±âÀÚ 2016-01-29 16:53
[Interview] ¡°ÀÓ»ó¿¡¼­ ¸í·áÇÏ°Ô Àû¿ëÇÒ ¼ö ÀÖ´Â BÇü°£¿° °¡À̵å¶óÀΡ± ÀÓ¼¼Çü ±âÀÚ 2016-01-29 15:45
¶óÀÎ
[Sub Story] ²÷ÀÓ¾øÀÌ ¿Ã¶ó°¡´Â ±â´É¼º ¿îµ¿Áúȯ À¯º´·ü ÀÓ¼¼Çü ±âÀÚ 2016-01-29 15:40
[Hot Discussion] [Case Review] À§»êºÐºñ¾ïÁ¦Á¦¿¡ ¹ÝÀÀÇÑ ½Äµµ ÇùÂø ÀÓ¼¼Çü ±âÀÚ 2016-01-29 11:20
[Sub Story] AGA ±Þ¼º °Ô½Ç¿° °¡À̵å¶óÀÎ ¾÷µ¥ÀÌÆ® ÀÓ¼¼Çü ±âÀÚ 2016-01-29 11:15
[Interview] ¡°±â´É¼º ¿îµ¿Áúȯ ½Ä½À°ü ¼­±¸È­¡¤°í·ÉÈ­ ¸Â¹°·Á Áö¼Ó Áõ°¡¡± ÀÓ¼¼Çü ±âÀÚ 2016-01-29 11:10
[Sub Story] ±¹³» CÇü°£¿° °í·ÉÀ¸·Î °¥¼ö·Ï Áõ°¡ ÀÓ¼¼Çü ±âÀÚ 2016-01-05 15:27
Back to Top